PreludeDx Appoints Dr. Karuna Mittal, Director, Research and Development

LAGUNA HILLS, Calif.: LAGUNA HILLS, Calif., Sept. 29, 2021 /PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today the addition of Karuna Mittal, Ph.D. as Director of Research and Development. This executive addition underscores PreludeDx's commitment to expanding its precision...

Click to view original post